Macquarie Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-604
Closed -$50K 2167
2022
Q3
$50K Sell
604
-467
-44% -$21.7K ﹤0.01% 1957
2022
Q2
$47K Hold
1,071
﹤0.01% 2069
2022
Q1
$77K Sell
1,071
-17,045
-94% -$1.23M ﹤0.01% 2024
2021
Q4
$1.47M Sell
18,116
-16,542
-48% -$1.66M ﹤0.01% 1459
2021
Q3
$4.03M Sell
34,658
-1,527
-4% -$200K ﹤0.01% 1168
2021
Q2
$6M Buy
36,185
+17,313
+92% +$2.7M ﹤0.01% 1073
2021
Q1
$2.63M Sell
18,872
-81,624
-81% -$13.3M ﹤0.01% 1096
2020
Q4
$17.4M Buy
100,496
+16,609
+20% +$2.69M 0.03% 563
2020
Q3
$11.7M Sell
83,887
-16,029
-16% -$2.14M 0.02% 608
2020
Q2
$11.9M Buy
99,916
+31,342
+46% +$3.72M 0.02% 592
2020
Q1
$6.86M Sell
68,574
-43,362
-39% -$5.22M 0.01% 643
2019
Q4
$13.2M Sell
111,936
-30,450
-21% -$3.02M 0.02% 603
2019
Q3
$12.2M Sell
142,386
-9,936
-7% -$752K 0.02% 559
2019
Q2
$9.88M Buy
+152,322
New +$9.48M 0.02% 610
2018
Q3
Sell
-36,548
Closed -$2.92M 2291
2018
Q2
$2.92M Buy
36,548
+6,437
+21% +$534K 0.01% 904
2018
Q1
$2.61M Sell
30,111
-3,649
-11% -$295K ﹤0.01% 914
2017
Q4
$2.33M Buy
33,760
+9,782
+41% +$783K ﹤0.01% 982
2017
Q3
$2.18M Sell
23,978
-1,644
-6% -$141K ﹤0.01% 957
2017
Q2
$1.91M Sell
25,622
-47,216
-65% -$3.78M ﹤0.01% 985
2017
Q1
$6.83M Buy
72,838
+2,748
+4% +$249K 0.01% 680
2016
Q4
$5.09M Sell
70,090
-9,400
-12% -$805K 0.01% 736
2016
Q3
$8.3M Sell
79,490
-3,819
-5% -$345K 0.02% 639
2016
Q2
$6.14M Buy
+83,309
New +$5.65M 0.01% 661

Other funds holding NVRO

Macquarie Group's NVRO Position: Q4 2022 in Review

Macquarie Group sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 604 shares — an estimated $50K sold.

Macquarie Group first reported a position in NVRO in Q2 2016 and held it in 23 quarters. The position peaked at $17.4M in Q4 2020. 169 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Macquarie Group reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 604 NEVRO CORP. shares in Q4 2022, an estimated $50K.
  • Macquarie Group first reported a position in NEVRO CORP. in Q2 2016 and held it in 23 quarters.
  • Macquarie Group's NEVRO CORP. position peaked at $17.4M in Q4 2020.
  • 169 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.